ArticleAmerican journal of translational research2026
Efficacy and safety of autologous hematopoietic stem cell transplantation for refractory systemic sclerosis after rituximab-bendamustine conditioning.
Chaoen Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.